Netherlands· NL-3c3d73c0d04a

Fulvestrant Sandoz 50 mg/ml, oplossing voor injectie in een voorgevulde spuit

A fulvestrant product containing fulvestrant, registered in Netherlands by Sandoz B.V.. The same ATC class is registered in 17 of our 19 countries.

ATC L02BA03

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about fulvestrantAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Fulvestrant is registered in 17 of 19 countries.

Countries holding a registration under ATC L02BA03 (fulvestrant), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
9 of them publish a price we can compare per daily dose

Search fulvestrant products by name

Fulvestrant · ATC L02BA03

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of fulvestrant costs, country by country.

Normalised to the WHO defined daily dose (16.7 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Fulvestrant · price per daily dose (16.7 mg)

USD · FX 28 Sept 2026

CH Switzerland$13.25

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: FULVESTRANT
Manufacturer: Sandoz B.V.
Country: Netherlands (NL)
ATC code: L02BA03
ATC class: Fulvestrant
Defined daily dose: 16.7 mg, P
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
115994

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

110 interactions on record for fulvestrant.

Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check fulvestrant against other medicines How interaction checks work

Fulvestrant · interactions on record

110 records

1 moderate
109 info

Most severe, free to view

Omacetaxine mepesuccinateL01XX40moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fulvestrant in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fulvestrant products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Fulvestrant +pharma, Fulvestrant Accord
Belgium · Fulvestrant Accord, Fulvestrant Eugia
Bulgaria · Fulvestrant Ever Pharma, Fulvestrant Pharmascience
Cyprus · Fulvestrant Accord, Fulvestrant Rompharm
Czechia · Fulvestrant Accord, Fulvestrant Ever Pharma
Germany · Fulvestrant 1 A Pharma, Fulvestrant Abz
Denmark · Fulvestrant "stada", Fulvestrant Accord
Estonia · Fulvestrant Accord, Fulvestrant Aliud
Spain · Afultrant, Ambiful
Finland · Fulvestrant Accord, Fulvestrant Ever Pharma
France · Fulvestrant, Fulvestrant Accord
United Kingdom (Northern Ireland) · Fulvestrant Accord Healthcare, Fulvestrant Dr. Reddy's
Greece · Fulvestrant Accord, Fulvestrant Demo
Croatia · Fulvestrant Accord, Fulvestrant Aptapharma
Hungary · Fulvestrant Aptapharma, Fulvestrant Elc
Ireland · Fulvestrant Accord Healthcare Ireland, Fulvestrant Ever Pharma
Iceland · Faslodex, Fulvestrant Accord
Italy · Fulvestrant Accord, Fulvestrant Aurobindo
Liechtenstein · Faslodex, Fulvestrant Mylan
Lithuania · Fulvestrant Aliud, Fulvestrant Orion
Luxembourg · Fulvestrant Teva
Latvia · Fulvestrant Aliud, Fulvestrant Stada
Malta · Fulvestrant Ever Pharma
Norway · Faslodex, Fulvestrant Accord
Poland · Fulvestrant Eugia, Fulvestrant Ever Pharma
Portugal · Ambiful, Cykostra
Romania · Falvax, Fulvestrant Accord
Sweden · Fulvestrant Accord, Fulvestrant Ever Pharma
Slovenia · Fulvestrant Accord, Fulvestrant Aptapharma
Slovakia · Fulvestrant Accord, Fulvestrant Ever Pharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/022f8ae3-0d85-4bc9-96b8-86f700117991
GET /v1/drugs/022f8ae3-0d85-4bc9-96b8-86f700117991?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Intramusculair gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h115994_smpc.pdf",
  "strength": null,
  "atc_label": "Fulvestrant",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg115994",
  "excipients": [
    "BENZYLALCOHOL (E 1519)",
    "BENZYLBENZOAAT",
    "CASTOROLIE",
    "ETHANOL 96 %"
  ],
  "substances": [
    "FULVESTRANT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h115994.pdf",
  "authorised_at": "2015/10/06",
  "procedure_number": "PT/H/1309/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "115994",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about fulvestrant.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console